Used primarily in the treatment of glaucoma, this compound helps reduce intraocular pressure by inhibiting carbonic anhydrase in the ciliary body of the eye, thereby decreasing aqueous humor production. It is often prescribed when other carbonic anhydrase inhibitors are not well tolerated or when combination therapy is needed. The drug may also be used adjunctively in certain cases of epilepsy and altitude sickness, although these are less common applications. Its systemic action allows for oral administration, making it a convenient option for long-term management of chronic conditions.